Your browser doesn't support javascript.
loading
[Real-world study on the efficacy and safety of first-line antiviral therapy for chronic hepatitis B].
Chang, C D; Dong, C; Zhao, S X; Yuan, X W; Zhang, X X; Zhao, D D; Dou, Y; Nan, Y M.
Affiliation
  • Chang CD; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
  • Dong C; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
  • Zhao SX; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
  • Yuan XW; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
  • Zhang XX; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
  • Zhao DD; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
  • Dou Y; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
  • Nan YM; Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Provincial Key Laboratory of study on Mechanism of Hepatic Fibrosis in Chronic Liver Disease, Shijiazhuang 050051, China.
Zhonghua Gan Zang Bing Za Zhi ; 31(8): 855-861, 2023 Aug 20.
Article in Zh | MEDLINE | ID: mdl-37723068
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B, Chronic Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Year: 2023 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B, Chronic Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Year: 2023 Type: Article Affiliation country: China